Financhill
Back

Exagen, Inc. Stock Predictions

Exagen, Inc. Stock Forecast

  • Is Exagen, Inc. Stock Undervalued?
    The current Exagen, Inc. [XGN] share price is $4.60. The Score for XGN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • XGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Exagen, Inc. Stock Go Up Next Year?

Data Unavailable

Exagen, Inc. Stock Rating

Data Unavailable

Exagen, Inc. Stock Price History

Is XGN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XGN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
exagen.com

52-Week Data

52-Week High:
12.23
52-Week Low:
2.67

Prediction Charts

Market Cap:
104.3M
Price in USD:
4.60
Volume:
459.8K
Beta:
1.43

Technical Analysis

SMA50:
6.82
SMA100:
8.76
SMA200:
7.92
52-Wk Change:
15.29%

Stock Predictions

  • Is Exagen, Inc. stock public?
    Yes, Exagen, Inc. is a publicly traded company.
  • What is the Exagen, Inc. stock quote today?
    The Exagen, Inc. stock price is 4.60 USD today.
  • How to buy Exagen, Inc. stock online?
    You can buy Exagen, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-5 6.02 5.95 6.02 5.74
Jan-6 6.06 6.09 6.66 5.85
Jan-7 6.10 6.02 6.20 5.96
Jan-8 5.96 6.17 6.27 5.96
Jan-9 6.24 6.34 6.75 5.94
Jan-12 6.32 5.95 6.61 5.91
Jan-13 5.94 5.15 6.05 5.14
Jan-14 5.15 5.09 5.34 4.75
Jan-15 5.09 4.83 5.09 4.82
Jan-16 4.83 4.69 5.05 4.67
Jan-20 4.63 4.74 4.80 4.46
Jan-21 4.73 4.73 4.88 4.41
Jan-22 4.74 4.89 5.05 4.72
Jan-23 4.86 4.60 4.91 4.53

Exagen, Inc. Earnings

Data Unavailable

Exagen, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.29 per share.

* Exagen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.